Phase II study of afatinib, an irreversible ErbB family blocker, in demographically and genotypically defined lung adenocarcinoma
De Grève, Jacques, Moran, Teresa, Graas, Marie-Pascale, Galdermans, Daniella, Vuylsteke, Peter, Canon, Jean-Luc, Schallier, Denis, Decoster, Lore, Teugels, Erik, Massey, Dan, Chand, Vikram K., VansteeТом:
88
Мова:
english
Журнал:
Lung Cancer
DOI:
10.1016/j.lungcan.2015.01.013
Date:
April, 2015
Файл:
PDF, 506 KB
english, 2015